Menghui Wang, Nanfang Li, Ying Zhang, Delian Zhang, Suofeiya Abulikemu, Yinchun Wang, Guli Nuer, Jianqiong Kong, Juhong Zhang, Zhitao Yan1, Hongjian Li, and Xiangyang Zhang
Objectives: Coexistence of primary aldosteronism and obstructive sleep apnea in hypertension is evidenced. However, aldosterone and renin activity is varying with apnea/hypopnea index changes in subjects with resistant hypertension. Thus, the aim is to investigate the optional cutoff value for aldosterone/renin activity to screen primary aldosteronism in patients with different status of apnea/hypopnea index.
Methods: 271 hypertensive male snores were evaluated via polysomnography and divided into two groups, group with apnea/hypopnea index >15 events/h and with apnea/hypopnea index <15 events/h. Primary aldosteronism was determined as following: subjects with plasma renin activity<1.0 ng/mL/h and aldosterone concentration>15 ng/dL performed saline infusion test, after which aldosterone concentration>5 ng/dL was a sign of primary aldosteronism. Receiver operating characteristic curve was applied to explore appropriate cutoff value for aldosterone/renin activity.
Results: 39 (14.4%) of the 271 were diagnosed with primary aldosteronism including 15 with apnea/hypopnea index <15 events/h and 24 with apnea/hypopnea index >15 events/h. Area under receiver operating characteristic curve was 0.97 (95%CI 0.94-0.99) in the group with apnea/hypopnea index >15 events/h and 0.91 (95%CI 0.87-0.96) in the group with apnea/hypopnea index <15 events/h. Appropriate cutoff value for aldosterone/renin activity is 29.1 ng/dL per ng/mL/h for the group with apnea/hypopnea index <15 events/h with sensitivity 100%, specificity 90% and 15.9 ng/dL per ng/mL/h for the group with apnea/hypopnea index >15 events/h with sensitivity 100%, specificity 69.7%. Youden index is 0.9 for the group with apnea/hypopnea index <15 events/h and 0.7 for the group with apnea/hypopnea index >15 events/h.
Conclusions: Optional cutoff values of aldosterone/renin activity to screening for primary aldosteronism should be considered in patients with different status of apnea/hypopnea index.
Comparte este artículo